Skip to content
Catalyst

PapersPMID:41236933

Basil (Ocimum basilicum) to Alleviate Anxiety in Patients With Major Depressive Disorder: A Randomized Placebo-Controlled Clinical Trial.

Brain and behavior2025The record ↗

findings
2
compound
1
endpoints
2
  1. Finding, moderate evidencelowersBeck Depression Inventory (BDI) total score
  2. Finding, moderate evidencelowersHamilton Anxiety Rating Scale (HAM-A) total score
Study, every finding
RCT · 4 weeks
Dose studied, every finding
1100 mg hydroalcoholic extract in 5 mL syrup, once nightly before sleep
Population, every finding
Adults aged 18-65 with major depressive disorder and concurrent anxiety (HAM-A 18 or above), all taking sertraline 50-100 mg/day in both arms; single-blind, 4 weeks

Study record

Design
randomised controlled trial
Species
human
Population
Adults aged 18-65 years with major depressive disorder and concurrent anxiety (HAM-A at least 18), treated with sertraline; basil hydroalcoholic leaf extract syrup (Ocimum basilicum) vs placebo syrup
Participants
60
Comparator
placebo
Duration
28 days
Endpoints measured
8